Recently, Hologic Inc. (HOLX) inked a definitive agreement to divest its LIFECODES business unit to Immucor Inc. to focus more on its core business activities. The divestiture is expected to close ...

Recently, Hologic Inc. (HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument–reagent systems space in the blood transfusion ...

Bedford-based medical device maker Hologic Inc. said it has successfully completed the sale of its Lifecodes business unit to Immucor Inc. Hologic has received $85 million in cash with the opportunity ...

Medical device maker Hologicannounced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant diagnostics, ...

Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced a definitive agreement to acquire the LIFECODES business, which ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Bedford, Mass.-based medical imaging and diagnostic test ...

BioWorld - Wednesday, October 29, 2025 See today's BioWorld MedTech Home » Deals roundup: Hologic completes sale of Lifecodes to Immucor To read the full story, subscribe or sign in.

Medical device maker Hologic (HOLX +0.24%) announced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant ...

Recently, Hologic Inc. ( HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument-reagent systems space in the blood transfusion ...